Magazine Article | February 1, 2017

The Enterprisers: CohBar - Producing Mitochondria Medicine

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Why shouldn’t our mitochondria want us to live long, prospering in good health? Why shouldn’t they — as symbiotic microbes turned cellular organelles with their own mini-genomes — carry genes that help ensure our healthful survival? After all, they ride around inside our cells, living on what we feed them, as they transform those elementals into the chemical fuel that powers us. In a variety of ways, they reach out and help keep our bodies whole and healthy as well. Many companies have sprung up around the idea of making medicine based on mitochondria’s role in health and disease, and one of them, CohBar, has chosen a unique way that avoids the common challenge of invading the cell’s interior to achieve therapeutic effects.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.